Investor Channel
NYSE:RPC
Introduction to Radient Pharmaceuticals
Douglas MacLellan, CEO & Chairman provides and overview of the business and highlights the importance of Radient's Onko-Sure cancer screening solutio...
July 9, 2010 | 1:04m
Introduction to Onko-Sure
Onko-Sure is Radient Pharmaceutical's lead product. Onko-sure is a cancer diagnostic for the screening of 14 different types of cancer.
July 9, 2010 | 1:12m
Describing the medical usefulness of Onko-Sure
Christopher Gee, Dir. of International Sales & Marketing discuss the scope Onko-Sure's ability to screen for a wide variety of cancer types.
July 9, 2010 | 53.45s
Sort:
|
Recent News & Press Releases
RADIENT PHARMA Launches New Corporate Video and Website
RADIENT PHARMA Enters Into A Letter of Intent ...
Stock Chart & Price Information
How Onko-Sure Works
Douglas MacLellan, CEO describes how Onko-Sure is a technological breakthrough within the cancer diagnostic industry.
subject: Opinion
July 12, 2010 | 49.34s
Onko-Sure and Colorectal Cancer
Douglas Maclellan talks about the unique attributes of Onko-Sure as it relates to colorectal cancer.
July 13, 2010 | 1:06m
Interview with Doug MacLellan
Mr. MacLellan talks about the importance of people embracing ongoing cancer screening.
subject: Research
July 12, 2010 | 2:04m
Disclaimer goes here
This InvestorChannel is managed by
